| Sub-speciality | Package Rate | A1 | A2 | A3 | A4 | A5 | A6 |
|---|
| BREAST CANCER | TN0209 : Adriamycin/Cyclophosphamide (AC) | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 |
| | TN0210 : 5- Fluorouracil A-C (FAC) | 3,720 | 3,720 | 3,720 | 3,720 | 3,720 | 3,720 |
| | TN0211 : AC (AC Then T) | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 |
| | TN0212 : Paclitaxel | 11,400 | 11,400 | 11,400 | 11,400 | 11,400 | 11,400 |
| | TN0213 : Cyclophosphamide/ Methotrexate / 5 Fluorouracil (CMF) | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| | TN0214 : Tamoxifen Tabs | Per Month 100 | Per Month 100 | Per Month 100 | Per Month 100 | Per Month 100 | Per Month 100 |
| | TN0215 : Aromatase Inhibitors | Per Month 1000 | Per Month 1000 | Per Month 1000 | Per Month 1000 | Per Month 1000 | Per Month 1000 |
| BLADDER CANCER | TN0216 : Bladder Cancer Weekly Cisplatin | 2,400 | 2,400 | 2,400 | 2,400 | 2,400 | 2,400 |
| | TN0217 : Methotrexate Vinblastine Adriamycin Cyclophosphamide (MVAC) (Outdated) CDDP + Gemcitabine | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 |
| LUNG CANCER | TN0218 : Cisplatin/Etoposide (IIIB) or Pl + Taxol | 8,400 | 8,400 | 8,400 | 8,400 | 8,400 | 8,400 |
| OESOPHAGEAL CANCER | TN0219 : Cisplatin- 5Fu | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 |
| GASTRIC CANCER | TN0220 : 5-Fu Leucovorin (Mcdonald Regimen) | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 |
| COLORECTAL CANCER | TN0221 : Monthly 5-Fu | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| | TN0222 : 5-Fluorouracil-Oxaliplatin Leucovorin (Folfox) (Stage III Only) | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 | 12,000 |
| OSTEOSARCOMA/ BONE TUMOURS | TN0223 : Cisplatin/Adriamycin | 2,400 | 2,400 | 2,400 | 2,400 | 2,400 | 2,400 |
| LYMPHOMA I) HODGKIN DISEASE | TN0224 : Adriamycin Bleomycin Vinblastine Dacarbazine (ABVD) | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 |
| LYMPHOMA II) NHL | TN0225 : Cyclophosphamide Adriamycin Vincristine Prednisone (CHOP) +Inj.Rituximab for CD20 + NHL | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 |
| MULTIPLE MYELOMA | TN0226 : Vincristine, Adriamycin, Dexamethasone (VAD) | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 |
| | TN0227 : Thalidomide + Dexamethasone (Oral) / + or - Lenalidomide 25Mg | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 |
| | TN0228 : Melphalan, Prednisone (Oral) | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 | 1,800 |
| WILM'S TUMOUR | TN0229 : SIOP/NWTS Regimen(Stages I - III) | Per Month 8400 | Per Month 8400 | Per Month 8400 | Per Month 8400 | Per Month 8400 | Per Month 8400 |
| HEPATOBLASTOMA - OPERABLE | TN0230 : Cisplatin Adriamycin | 2,400 | 2,400 | 2,400 | 2,400 | 2,400 | 2,400 |
| CERVICAL CANCER | TN0231 : Cervical Cancer Weekly Cisplatin | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
| CHILDHOOD B-CELL LYMPHOMAS | TN0232 : Variable Regimen | Upto 12000 | Upto 12000 | Upto 12000 | Upto 12000 | Upto 12000 | Upto 12000 |
| NEUROBLASTOMA (STAGES I TO III) | TN0233 : Neuroblastoma ( Stages I-III ) Variable Regimen | Upto 10000 | Upto 10000 | Upto 10000 | Upto 10000 | Upto 10000 | Upto 10000 |
| RETINIBLASTOMA | TN0234 : Carbo/ Etoposide/ Vincristine | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 |
| HISTIOCYTOSIS | TN0235 : Histiocytosis Variable Regimen MTX + Etopioside VCR | Upto 8000 | Upto 8000 | Upto 8000 | Upto 8000 | Upto 8000 | Upto 8000 |
| RHABDOMYOSARCOMA | TN0236 : Vincristine-Actinomycin-Cyclophosphamide (VACTC) Based Chemo | Per Month 10800 | Per Month 10800 | Per Month 10800 | Per Month 10800 | Per Month 10800 | Per Month 10800 |
| EWING'S SARCOMA | TN0237 : Ewings Sarcoma Variable Regimen | Upto 9000 | Upto 9000 | Upto 9000 | Upto 9000 | Upto 9000 | Upto 9000 |
| ACTE MYELOID LEUKAMIA | TN0238 : Induction Phase | Upto 60000 | Upto 60000 | Upto 60000 | Upto 60000 | Upto 60000 | Upto 60000 |
| | TN0239 : Consolidation Phase | Upto 40000 | Upto 40000 | Upto 40000 | Upto 40000 | Upto 40000 | Upto 40000 |
| | TN0240 : Maintenance | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 |
| ACUTE LYMPHOBLASTIC LEUKAMIA | TN0241 : Induction 1st and 2nd Months | Upto 50000 | Upto 50000 | Upto 50000 | Upto 50000 | Upto 50000 | Upto 50000 |
| | TN0242 : Induction 3rd, 4th, 5th | Upto 20000 | Upto 20000 | Upto 20000 | Upto 20000 | Upto 20000 | Upto 20000 |
| | TN0243 : Induction Maintenance | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 |
| FOR UNLISTED REGIMEN | TN0244 : Palliative Chemotherapy | Upto 5000 | Upto 5000 | Upto 5000 | Upto 5000 | Upto 5000 | Upto 5000 |
| ACUTE LYMPHOBLASTIC LEUKAMIA - FOR TERMINALLY ILL CANCER PATIENT | TN0245 : Palliative and Supportive Therapy | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 |
| VULVAL CANCER | TN0246 : Vulval Cancer Cisplatin/5-Fu | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 |
| VAGINAL CANCER | TN0247 : Vaginal Cancer Cisplatin/5-Fu | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 |
| OVARIAN CANCER | TN0248 : Carboplatin/ Paclitaxel | 12,600 | 12,600 | 12,600 | 12,600 | 12,600 | 12,600 |
| OVARY GERM CELL TUMOUR | TN0249 : Ovary- Germ Cell Tumor Bleomycin-Etoposide-Cisplatin (BEP) | 9,600 | 9,600 | 9,600 | 9,600 | 9,600 | 9,600 |
| GESTATIONAL TROPHOBLASTS DS | TN0250 : Weekly Methotrexate | 720 | 720 | 720 | 720 | 720 | 720 |
| | TN0251 : Actinomycin | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 |
| HIGH RISK | TN0252 : Etoposide-Methotrexate-Actinomycin / Cyclophosphamide �vincristine (EMA-CO) | 7,200 | 7,200 | 7,200 | 7,200 | 7,200 | 7,200 |
| TESTICULAR CANCER | TN0253 : Testicular Cancer Bleomycin-Etoposide-Cisplatin (BEP) | 9,600 | 9,600 | 9,600 | 9,600 | 9,600 | 9,600 |
| PROSTATE CANCER | TN0254 : Hormonal Therapy | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 | Per Month 3600 |
| COLORECTAL CANCER STAGE 2 & 3 | TN0255 : Xelox Along With Adjuvant Chemotherapy of As-I | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 | 4,800 |
| | TN0256 : 1st Line IV Antibiotics and Other Supportive Therapy ( Third Generation Cephalosporin, Aminoglycoside Etc.,), Anti Fungal,Inj. G-Csf 300Micro GM till Blood Count Returns to Normal | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 |
| | TN0257 : 2nd Line IV Antibiotics and Other Supportive Therapy (Carbapenems, Fourth Generation Cephalosporins, Piperacillin, Anti-Fungal . Azoles Etc.,) | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 |
| MULTIPLE MYELOMA | TN0258 : Zoledronic Acid Along with Adjuvant Chemotherapy of AS-I | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 | 3,600 |
| | TN0259 : CML Curable T. Imatinib | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| | TN0260 : CLL - Bendamustine 90Mg Per Meter Sq D1 & D2, T.Chlorambucil, T.Fludarabine | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| | TN0261 : MDS T.Lenalidomide, Azacytidine | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| | TN0262 : CD 20 +Ve Lymphomas Inj.Rituximab 500 Microgram (6 Injections once In 3 Weeks) | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |